Back

Effect of catheter ablation vs medical therapy on cardiovascular outcomes in hypertrophic cardiomyopathy with atrial fibrillation

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel insights in catheter ablation for atrial fibrillation Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Daehoon Kim

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

8 More presentations in this session

Presentation thumbnail
Risk factors for procedure-related complications in very elderly patients undergoing atrial fibrillation ablation: analysis from the Japan Ablation Registry
Doctor K. Inoue (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Tricuspid regurgitation in atrial fibrillation: correlation to left atrial myopathy and improvement post ablation
Doctor J. Lee (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Impact of conduction velocity in left atrium assessing with omnipolar technology in patients with atrial fibrillation
Doctor Y. Enomoto (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Feasibility and efficacy assessment of a novel size-adjustable cryoballoon for ablation of atrial fibrillation in a multicenter clinical setting
Doctor M. Narducci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Timing of early recurrence of atrial fibrillation during the blanking period after catheter ablation for persistent atrial fibrillation and implications for long-term success: a multicentre study
Doctor P. Tang (Oxford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights in catheter ablation for atrial fibrillation

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The impact of the catheter ablation on long-term prognosis in patients with hypertrophic cardiomyopathy and atrial fibrillation
thumbnail
Congress Presentation
Long-term efficacy and safety of ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Nationwide trends in utilization and safety of ventricular arrythmia ablation in patients with hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources